Education
About Us
Working with TipRanks
Follow Us
EZZ Life Science Holdings Ltd. (AU:EZZ)
ASX:EZZ
EZZ Stock Chart & Stats
AU$1.48
-AU$0.25(-8.71%)
At close: 4:00 PM EST
AU$1.48
-AU$0.25(-8.71%)
Day’s Range― - ―
52-Week RangeAU$1.29 - AU$3.38
Previous CloseN/A
Volume93.44K
Average Volume (3M)49.70K
Market Cap
AU$68.17M
Enterprise ValueAU$89.84M
Total Cash (Recent Filing)AU$20.85M
Total Debt (Recent Filing)AU$304.49K
Price to Earnings (P/E)9.9
Beta0.28
Next Earnings
Mar 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.66%
Share Statistics
EPS (TTM)0.07
Shares Outstanding47,173,200
10 Day Avg. Volume67,551
30 Day Avg. Volume49,696
Financial Highlights & Ratios
PEG Ratio-2.57
Price to Book (P/B)3.85
Price to Sales (P/S)1.62
P/FCF Ratio26.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EZZ Life Science Holdings Ltd. News
EZZ FAQ
What was EZZ Life Science Holdings Ltd.’s price range in the past 12 months?
EZZ Life Science Holdings Ltd. lowest share price was AU$1.29 and its highest was AU$3.38 in the past 12 months.
What is EZZ Life Science Holdings Ltd.’s market cap?
EZZ Life Science Holdings Ltd.’s market cap is AU$68.17M.
When is EZZ Life Science Holdings Ltd.’s upcoming earnings report date?
EZZ Life Science Holdings Ltd.’s upcoming earnings report date is Mar 02, 2026 which is in 71 days.
How were EZZ Life Science Holdings Ltd.’s earnings last quarter?
EZZ Life Science Holdings Ltd. released its earnings results on Aug 29, 2025. The company reported AU$0.075 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.075.
Is EZZ Life Science Holdings Ltd. overvalued?
According to Wall Street analysts EZZ Life Science Holdings Ltd.’s price is currently Overvalued.
Does EZZ Life Science Holdings Ltd. pay dividends?
EZZ Life Science Holdings Ltd. pays a Semiannually dividend of AU$0.02 which represents an annual dividend yield of 2.66%. See more information on EZZ Life Science Holdings Ltd. dividends here
What is EZZ Life Science Holdings Ltd.’s EPS estimate?
EZZ Life Science Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EZZ Life Science Holdings Ltd. have?
EZZ Life Science Holdings Ltd. has 47,173,200 shares outstanding.
What happened to EZZ Life Science Holdings Ltd.’s price movement after its last earnings report?
EZZ Life Science Holdings Ltd. reported an EPS of AU$0.075 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.508%.
Which hedge fund is a major shareholder of EZZ Life Science Holdings Ltd.?
Currently, no hedge funds are holding shares in AU:EZZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EZZ Life Science Holdings Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:EZZ Sentiment 90%
Sector Average 68%
Sector Average 68%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-34.51%
12-Months-Change
Fundamentals
Return on Equity
27.24%
Trailing 12-Months
Asset Growth
32.89%
Trailing 12-Months
Company Description
EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Ltd. (EZZ) is a health and wellness company focused on developing, manufacturing, and distributing innovative dietary supplements and health products. Operating primarily in the nutraceutical sector, EZZ offers a range of products aimed at enhancing health and well-being, including supplements that support immune health, energy levels, and overall vitality. The company emphasizes research and development to create high-quality formulations that cater to the evolving needs of health-conscious consumers.
Technical Analysis
Amplia Therapeutics
―
Imugene
―
Alterity Therapeutics
―
Recce Pharmaceuticals Ltd.
―
Arovella Therapeutics Limited
―
Options Prices
Currently, No data available
---